- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04811859
The Effect of Inspiratory Muscle Training in Post COVID-19 Patients
March 22, 2021 updated by: Istinye University
The Effect of Inspiratory Muscle Training on Respiratory Muscle Strength, Respiratory Functions and Functional Capacity in Post COVID-19 Patients
The COVID-19 infection, which is considered as a pandemic by the World Health Organization, affects the whole world.
COVID-19 is an infectious respiratory disease caused by SARS-CoV-2.
It is stated in early studies that after COVID-19 infection, there are adverse effects on both the peripheral and respiratory muscles along with the pulmonary system involvement.
The purpose of our study; To examine the effect of Inspiratory Muscle Training (IMT) on respiratory muscle strength, respiratory functions and functional capacity in PostCOVID-19 patients.
Patients who have been hospitalized and discharged with the diagnosis of COVID-19 in Istinye University hospitals, at least 6 weeks have passed since the infection, the PCR test has turned negative will be taken.
The evaluation and treatment of the patients will be carried out in the Education and Research Units of Istinye University Physiotherapy and Rehabilitation Department.
Patients included in the study will be randomly divided into two groups, study and control groups.
Demographic evaluation form, Post Covid Functional Status Scale, Charlson Comorbidity Index, Modified Medical Research Council (MMRC) Dyspnea scale, Corbin posture analysis, Respiratory function test, Respiratory muscle strength measurement, Respiratory Muscle Endurance measurement, 6-minute walking test (6 MWT) ), Peripheral Muscle Strength, Grip Strength, Hospital Anxiety and Depression Scale (HADS), Breathlessness Perception Questionnaire (BBQ) and Nottingham Health Profile Questionnaire will be used.
In the study group, IMT will be applied at 40% of the maximum inspiratory pressure (MIP) for eight weeks, every day of the week, twice a day for 15 minutes.
The patients will come for a control once a week, the MIP values will be measured again and the new training intensity will be determined at 40% of the new MIP value.
The control group will be given a constant training of 15 minutes at 10% of the MIP, twice a day, every day of the week for eight weeks.
Evaluations of the study and control groups will be made at the beginning and after eight weeks.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
İstanbul, Turkey, 34010
- Recruiting
- Istinye University
-
Contact:
- Ali Osman Çırak, MSc, PT
- Phone Number: +905541960150
- Email: aliosman_cirak@hotmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adults ages 18-70
- Being clinically stable,
- Having COVID-19 infection and at least 6 weeks after infection
- Being between Grade 2-4 according to Post-COVID Functional Status Scale
- Regular participation in treatment
- To read, write and understand Turkish
- Volunteering to participate in research
Exclusion Criteria:
- Presence of mental and cognitive impairments
- Having an orthopedic, neurological disease that prevents exercise
- Uncontrolled hypertension, having a cardiovascular disease
- Pregnancy and breastfeeding
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Study Group
In the study group, Inspiratory Muscle Training will be applied with Threshold IMT device (Respironics, USA) at 40% of the maximum inspiratory pressure value for eight weeks, every day of the week, twice a day for 15 minutes.
The patients will come for a control once a week, the maximum inspiratory pressure will be measured again and the new training intensity will be determined at 40% of the new maximum inspiratory pressure.
|
Inspiratory Muscle Training is a form of resistance (weight) training which strengthens the muscles that you use to breathe.
When these muscles are strengthened regularly for a period of a few weeks they adapt, becoming stronger and being able to work for longer.
|
|
SHAM_COMPARATOR: Control group
In the control group, Inspiratory Muscle Training will be applied with Threshold IMT device (Respironics, USA) at 10% of the maximum inspiratory pressure value for eight weeks, every day of the week, twice a day for 15 minutes.
The exercise workload will not be increased and will remain the same.
It will run at 10% of maximum inspiratory pressure for eight weeks.
|
Inspiratory Muscle Training is a form of resistance (weight) training which strengthens the muscles that you use to breathe.
When these muscles are strengthened regularly for a period of a few weeks they adapt, becoming stronger and being able to work for longer.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PostCovid Functional Status Scale
Time Frame: eight weeks
|
PostCovid Functional Status Scale: It will be used to assess the functional status of patients after COVID-19 infection.
It divides the functional status of the patients into stages between 0 and 4.
|
eight weeks
|
|
Pulmonary Function Test
Time Frame: eight weeks
|
Pulmonary Function Test will be performed using a portable spirometry according to the guidelines of the American Thoracic Society.
Forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), and peak expiratory flow (PEF) will be expressed as the percentages of the predicted values.
|
eight weeks
|
|
Inspiratory muscle strength
Time Frame: eight weeks
|
Inspiratory muscle strength are the static inspiratory pressure measured at the mouth.
It is called maximal inspiratory pressure (MIP) and it will be assessed using an electronic pressure transducer.
The MIP will be measured at residual volume.
|
eight weeks
|
|
Functional capacity
Time Frame: eight weeks
|
Six-minute walk test (6MWT) will be applied in a 30-m unobstructed corridor.
Patients and controls will be instructed to walk their own pace but to cover as much meter as possible within 6 min.The distance will be recorded.
|
eight weeks
|
|
Expiratory muscle strength
Time Frame: eight weeks
|
Expiratory muscle strength are the static expiratory pressure measured at the mouth.
It is called maximal expiratory pressure (MEP) and it will be assessed using an electronic pressure transducer.
The MEP will be measured from total lung capacity.
|
eight weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 10, 2021
Primary Completion (ANTICIPATED)
January 10, 2022
Study Completion (ANTICIPATED)
March 10, 2022
Study Registration Dates
First Submitted
February 25, 2021
First Submitted That Met QC Criteria
March 22, 2021
First Posted (ACTUAL)
March 23, 2021
Study Record Updates
Last Update Posted (ACTUAL)
March 23, 2021
Last Update Submitted That Met QC Criteria
March 22, 2021
Last Verified
March 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ISUCPR
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Covid19
-
Anavasi DiagnosticsNot yet recruiting
-
Ain Shams UniversityRecruiting
-
Israel Institute for Biological Research (IIBR)Completed
-
Colgate PalmoliveCompleted
-
Christian von BuchwaldCompleted
-
Luye Pharma Group Ltd.Shandong Boan Biotechnology Co., LtdActive, not recruiting
-
University of ZurichLabor Speiz; Swiss Armed Forces; Universitatsspital ZurichEnrolling by invitation
-
Alexandria UniversityCompleted
Clinical Trials on Inspiratory Muscle Training
-
Ceren Derya GültekinRecruitingPulmonary Rehabilitation | Inspiratory Muscle Training | Hematopoietic Stem Cell Transplantation (HSCT)Turkey
-
Elisabethinen HospitalUnknownStem Cell Transplantation | Inspiratory Muscle Training | Respiratory Muscle TrainingAustria
-
Universidad Francisco de VitoriaNot yet recruitingFrailty Syndrome | Respiratory Muscle Weakness | Age-Related Frailty | Geriatric Health
-
Istinye UniversityCompletedStroke | Respiratory MusclesTurkey
-
Dokuz Eylul UniversityDokuz Eylül University, Scientific Research Projects Coordination UnitCompleted
-
University of British ColumbiaNatural Sciences and Engineering Research Council, CanadaCompletedRespiratory Muscles | Breathing ExercisesCanada
-
Universidad Complutense de MadridColegio Profesional de Fisioterapeutas de la Comunidad de Madrid, Madrid,...CompletedQuality of Life | Covid19 | Respiratory Muscle Training | Respiratory Function Test | Psychosocial FactorSpain
-
Hong Kong Metropolitan UniversityNot yet recruiting
-
Universidad Francisco de VitoriaNot yet recruitingFrailty Syndrome | Respiratory Muscle Weakness | Age-Related Frailty | Geriatric Health
-
Universidad Francisco de VitoriaActive, not recruitingFrailty Syndrome | Respiratory Muscle Weakness | Age-Related Frailty | Geriatric HealthSpain